US$ 21.38
ghk-cu clinical studies human trials Copper Peptide Regeneration Review (2018) — Research Summary GHK-Cu Research Peptide Australia |
Description
Clinical interventions in aging, 1(4), 327-348

Patient education: Tinnitus (ringing in the ears) (Beyond the Basics)

Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open-label feasibility trial

Systemic administration of the neurotensin NTS-receptor agonist PD149163 improves performance on a memory task in naturally deficient male brown Norway rats